PLX Financial Facts
NET LOSS FOR THE PERIOD: -7.29MOPERATING LOSS: -6.65M
See Full Income Statement
Other: 5.84M
Deferred revenues: 453K
See Full Balance Sheet
Protalix Biotherapeutics, Inc. (PLX) Earnings
|
Expand Research on PLX
| Next EPS Date | 5/8/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +11.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/17  |
Q117 | -$0.48 | N/A | N/A | $2.9M | $679K | N/A |  | | Details | |
| 8/16/21 |  |
Q221 | -$0.25 | -$0.08 | -$0.17 | $6.43M | $8.3M | N/A | | | Details |
| 8/7/23 | Q223 | -$0.16 | N/A | N/A | $24.84M | $10.22M | N/A | | | Details | |
| 11/7/19 | |
Q319 | -$0.13 | -$0.03 | -$0.10 | $12.09M | $11.6M | N/A | | | Details |
| 3/13/14 | Q413 | -$0.12 | -$0.02 | -$0.10 | N/A | N/A | N/A | | | Details | |
| 11/15/21 | |
Q321 | -$0.09 | $0.00 | -$0.09 | $12.05M | $6.9M | N/A | | | Details |
| 2/27/23 | Q422 | -$0.22 | -$0.15 | -$0.07 | $62.89M | $6.12M | N/A | | | Details | |
| 8/15/22 | Q222 | -$0.11 | -$0.05 | -$0.06 | $8.75M | $15.1M | N/A | | | Details |
